Journal of Clinical Pediatrics ›› 2024, Vol. 42 ›› Issue (2): 116-120.doi: 10.12372/jcp.2024.22e0958
Previous Articles Next Articles
ZHOU Yang, WU Yali, DING Yan()
Received:
2022-07-13
Online:
2024-02-15
Published:
2024-02-02
ZHOU Yang, WU Yali, DING Yan. Clinical characteristics and genotype analysis of adenosine deaminase 2 (ADA2) deficiency in China: a report of three cases[J].Journal of Clinical Pediatrics, 2024, 42(2): 116-120.
[1] |
Pinto B, Deo P, Sharma S, et al. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment[J]. Clin Rheumatol, 2021, 40(10): 3883-3896.
doi: 10.1007/s10067-021-05711-w pmid: 33791889 |
[2] |
Zhou Q, Yang D, Ombrello AK, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2[J]. N Engl J Med, 2014, 370(10): 911-920.
doi: 10.1056/NEJMoa1307361 |
[3] |
Zhang B, Sun Y, Xu N, et al. Adult-onset deficiency of adenosine deaminase 2—a case report and literature review[J]. Clinical Rheumatology, 2021, 40(10): 4325-4339.
doi: 10.1007/s10067-021-05587-w |
[4] | 张冰清, 张硕, 王涛, 等. 第544例结节红斑—血小板减少—青斑样血管病—免疫缺陷[J]. 中华医学杂志, 2021, 101(31): 2485-2487. |
[5] | 柏翠, 郭兴青, 高婷婷, 等. 儿童腺苷脱氨酶2缺乏症2例并文献复习[J]. 中华实用儿科临床杂志, 2020, 35(21): 1674-1677. |
[6] |
Human A, Pagnoux C. Diagnosis and management of ADA2 deficient polyarteritis nodosa[J]. Int J Rheum Dis, 2019, 22 (Suppl 1): 69-77.
doi: 10.1111/apl.2019.22.issue-S1 |
[7] |
Fayand A, Chasset F, Boutboul D, et al. DADA2 diagnosed in adulthood versus childhood: A comparative study on 306 patients including a systematic literature review and 12 French cases[J]. Semin Arthritis Rheum, 2021, 51(6): 1170-1179.
doi: 10.1016/j.semarthrit.2021.09.001 |
[8] |
Meyts I, Aksentijevich I. Deficiency of Adenosine Deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment[J]. J Clin Immunol, 2018, 38(5): 569-578.
doi: 10.1007/s10875-018-0525-8 pmid: 29951947 |
[9] |
Caorsi R, Penco F, Grossi A, et al. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study[J]. Ann Rheum Dis, 2017, 76(10): 1648-1656.
doi: 10.1136/annrheumdis-2016-210802 pmid: 28522451 |
[10] |
Caratsch L, Schnider C, Moi L, et al. Adenosine deaminase 2 deficiency: a disease with multiple presentations[J]. Rev Med Suisse, 2022, 18(776): 669-673.
doi: 10.53738/REVMED.2022.18.776.669 pmid: 35385618 |
[11] |
Sharma A, Naidu G, Sharma V, et al. Deficiency of adenosine deaminase 2 in adults and children: experience from India[J]. Arthritis Rheumatol, 2021, 73(2): 276-285.
doi: 10.1002/art.v73.2 |
[12] |
Nanthapisal S, Murphy C, Omoyinmi E, et al. Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases[J]. Arthritis Rheumatol, 2016, 68(9): 2314-2322.
doi: 10.1002/art.v68.9 |
[13] |
Van Nieuwenhove E, Humblet-Baron S, Van Eyck L, et al. ADA2 deficiency mimicking idiopathic multicentric castleman disease[J]. Pediatrics, 2018, 142(3): e20172266.
doi: 10.1542/peds.2017-2266 |
[14] |
Van Montfrans JM, Hartman EA, Braun KP, et al. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations[J]. Rheumatology (Oxford), 2016, 55(5): 902-910.
doi: 10.1093/rheumatology/kev439 pmid: 26867732 |
[15] |
Westendorp WF, Nederkoorn PJ, Aksentijevich I, et al. Unexplained early-onset lacunar stroke and inflammatory skin lesions: Consider ADA2 deficiency[J]. Neurology, 2015, 84(20): 2092-2093.
doi: 10.1212/WNL.0000000000001581 pmid: 25888558 |
[16] |
Batu ED, Karadag O, Taskiran EZ, et al. A case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations[J]. J Rheumatol, 2015, 42(8): 1532-1534.
doi: 10.3899/jrheum.150024 pmid: 26233953 |
[17] |
Uettwiller F, Sarrabay G, Rodero MP, et al. ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters[J]. RMD Open, 2016, 2(1): e000236.
doi: 10.1136/rmdopen-2015-000236 |
[18] |
Schena F, Penco F, Volpi S, et al. Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patients[J]. Eur J Immunol, 2021, 51(1): 206-219.
doi: 10.1002/eji.v51.1 |
[19] |
Lee PY, Kellner ES, Huang Y, et al. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2)[J]. J Allergy Clin Immunol, 2020, 145(6): 1664-1672.
doi: S0091-6749(20)30030-0 pmid: 31945408 |
[20] |
Özen S, Batu ED, Taşkıran EZ, et al. A monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2[J]. J Rheumatol, 2020, 47(1): 117-125.
doi: 10.3899/jrheum.181384 pmid: 31043544 |
[21] |
Navon Elkan P, Pierce SB, Segel R, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy[J]. N Engl J Med, 2014, 370(10): 921-931.
doi: 10.1056/NEJMoa1307362 |
[22] |
Van Eyck L Jr., Hershfield MS, Pombal D, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency[J]. J Allergy Clin Immunol, 2015, 135(1): 283-287.
doi: 10.1016/j.jaci.2014.10.010 pmid: 25457153 |
[23] |
Garg N, Kasapcopur O, Foster J, 2nd, et al. Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy[J]. Eur J Pediatr, 2014, 173(6): 827-830.
doi: 10.1007/s00431-014-2320-8 pmid: 24737293 |
[24] | 郭莉, 卢美萍. 腺苷脱氨酶2缺乏症研究进展[J]. 中华儿科杂志, 2020, 58(6): 520-523. |
[25] |
Zhang B, Xu N, Chen J, et al. Treatment and outcome in deficiency of adenosine deaminase 2: a literature review[J]. J Investig Allergol Clin Immunol, 2021, 32(1): 13-22.
doi: 10.18176/jiaci |
[26] |
Ombrello AK, Qin J, Hoffmann PM, et al. Treatment strategies for deficiency of adenosine deaminase 2[J]. The New England journal of medicine, 2019, 380(16): 1582-1584.
doi: 10.1056/NEJMc1801927 pmid: 30995379 |
[27] |
Gibson KM, Morishita KA, Dancey P, et al. Identification of novel adenosine deaminase 2 gene variants and varied clinical phenotype in pediatric vasculitis[J]. Arthritis Rheumatol, 2019, 71(10): 1747-1755.
doi: 10.1002/art.v71.10 |
[28] |
Lee PY. Vasculopathy, Immunodeficiency, and bone marrow failure: the intriguing syndrome caused by deficiency of adenosine deaminase 2[J]. Front Pediatr, 2018, 6: 282.
doi: 10.3389/fped.2018.00282 |
[1] | LI Niu, LI Lei, CHEN Huiwen, WANG Jian, ZHANG Hao. Construction of the Shanghai children's rare disease registration database and summary of phased data [J]. Journal of Clinical Pediatrics, 2024, 42(2): 102-109. |
[2] | ZHAO Shuai, MA Ang, LUO Shuying, XIA Songchen, HAO Chanjuan, LI Wei, WEI Haiyan, ZHANG Yaodong. Clinical characteristics of 20 rare diseases in children based on specific disease data [J]. Journal of Clinical Pediatrics, 2024, 42(2): 110-115. |
[3] | SUN Ruonan, LI Bohan, ZHENG Defei, ZHAO Xiaying, LIN Ziyun, HU Yixin, GAO Li, GAO Jing, LI Jie, LU Jun, XIAO Peifang, PAN Jian, LING Jing, FANG Fang, HU Shaoyan. Factors related to bronchiolitis obliterans syndrome in pediatric patients survived longer than 100 days after hematopoietic stem cell transplantation [J]. Journal of Clinical Pediatrics, 2024, 42(2): 139-145. |
[4] | LIANG Huan, ZHANG Huiwen. Diagnosis of a child with Duchenne muscular dystrophy using optical genome mapping [J]. Journal of Clinical Pediatrics, 2024, 42(2): 146-150. |
[5] | YAO Qianghua, WANG Yingchao, WANG Dao, LIU Yufeng. Analysis of risk factors for early death of acute promyelocytic leukemia in children [J]. Journal of Clinical Pediatrics, 2024, 42(1): 53-57. |
[6] | JIN Mei, LIU Jing, LIU Kang, ZHAO Libo, ZHAO Ziwei, SUN Suzhen. Characteristics of neurofilament light chain levels in cerebrospinal fluid of Guillain-Barre syndrome in children [J]. Journal of Clinical Pediatrics, 2024, 42(1): 58-62. |
[7] | GENG Tian, YU Zhongsu, ZHOU Xixi, LIU Bo, ZHANG Huihua, LI Zhongyue. Analysis of eradication effect and influencing factors of triple therapy of Helicobacter pylori in children [J]. Journal of Clinical Pediatrics, 2024, 42(1): 63-69. |
[8] | ZHAO Fangyuan, CHEN Yonghua, WANG Kana, WANG Chunlin. Analysis of correlation between Turner syndrome karyotype and autoimmune thyroid disease [J]. Journal of Clinical Pediatrics, 2024, 42(1): 70-74. |
[9] | DAI Yinliang, HE Hailong, FAN Liyan, LI Jie, LU Jun, XIAO Peifang, LING Jing, ZHENG Jiajia, DU Zhizhuo, HU Shaoyan. Successful rescue of progression from Fanconi anemia to acute myeloid leukemia by allogeneic hematopoietic stem cell transplantation with decitabine maintenance: a case report [J]. Journal of Clinical Pediatrics, 2024, 42(1): 75-79. |
[10] | ZOU Liping. Childhood encephalopathy: a group of diseases associated with various diseases [J]. Journal of Clinical Pediatrics, 2023, 41(9): 641-643. |
[11] | ZHANG Weihua, ZOU Liping, REN Haitao, GUAN Hongzhi. Beware of the pitfalls in diagnosis and treatment of autoimmune encephalitis in children [J]. Journal of Clinical Pediatrics, 2023, 41(9): 644-649. |
[12] | HOU Chi, CHEN Wenxiong, LIAO Yinting, WU Wenxiao, TIAN Yang, ZHU Haixia, PENG Bingwei, ZENG Yiru, WU Wenlin, CHEN Zongzong, LI Xiaojing. Clinical analysis of autoimmune glial fibrillary acidic protein astrocytopathy in children [J]. Journal of Clinical Pediatrics, 2023, 41(9): 656-660. |
[13] | YANG Yating, CAI Yuehao, FANG Qiong, CHEN Lang, CHEN Qiaobin, LIN Zhi, WU Feifei, LIN Meng. Clinical analysis of idiopathic and symptomatic occipital lobe epilepsy in children [J]. Journal of Clinical Pediatrics, 2023, 41(9): 668-673. |
[14] | HOU Ruolin, WU Jing, LI Ling. Pediatric autoimmune encephalitis with brain MRI showing meningeal thickening and enhancement [J]. Journal of Clinical Pediatrics, 2023, 41(9): 674-679. |
[15] | WU Yuefang, SUN Yanling, WU Wanshui, DU Shuxu, LI Miao, SUN Liming. Analysis of prognostic factors and survival status of group 4 medulloblastoma in children [J]. Journal of Clinical Pediatrics, 2023, 41(9): 686-691. |
|